z-logo
open-access-imgOpen Access
Peritoneal Dialysis Fluid and Some of its Components Potentiate Fibrocyte Differentiation
Author(s) -
Herlihy Sarah E.,
Starke Hannah E.,
Lopez-Anton Melisa,
Cox Nehemiah,
Keyhanian Katayoon,
Fraser Donald J.,
Gomer Richard H.
Publication year - 2016
Publication title -
peritoneal dialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.79
H-Index - 83
eISSN - 1718-4304
pISSN - 0896-8608
DOI - 10.3747/pdi.2014.00284
Subject(s) - fibrocyte , peritoneal dialysis , fibrosis , medicine , fibroblast , peritoneal fluid , pathology , in vitro , microbiology and biotechnology , chemistry , biology , biochemistry
Long-term peritoneal dialysis (PD) often results in the development of peritoneal fibrosis. In many other fibrosing diseases, monocytes enter the fibrotic lesion and differentiate into fibroblast-like cells called fibrocytes. We find that peritoneal tissue from short-term PD patients contains few fibrocytes, while fibrocytes are readily observed in the peritoneal membrane of long-term PD patients. The PD fluid Dianeal (Baxter Healthcare Corporation, Deerfield, IL, USA) contains dextrose, a number of electrolytes including sodium chloride, and sodium lactate. We find that PD fluid potentiates human fibrocyte differentiation in vitro and implicates sodium lactate in this potentiation. The plasma protein serum amyloid P (SAP) inhibits fibrocyte differentiation. Peritoneal dialysis fluid and sodium chloride decrease the ability of human SAP to inhibit human fibrocyte differentiation in vitro . Together, these results suggest that PD fluid contributes to the development of peritoneal fibrosis by potentiating fibrocyte differentiation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom